Esperion Therapeutics (ESPR) Times Interest Earned (2012 - 2026)
Esperion Therapeutics (ESPR) reported Times Interest Earned of -$0.33 for Q1 2026, up 70.77% on a YoY basis from -$0.19 in Q1 2025, and down 108.83% quarter-over-quarter from $3.77 in Q4 2025.
Esperion Therapeutics (ESPR) Times Interest Earned (2012 - 2026) Analysis & Trends
Esperion Therapeutics has reported Times Interest Earned for 14 years, with the latest figure at -$0.33 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 70.77% year-over-year to -$0.33; the trailing twelve-month figure through Mar 2026 stood at $0.89 (up 262.69% YoY), and the FY2025 full-year result was $0.71, down 22.41% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.33, down from $3.77 in the prior quarter.
- The five-year high for Times Interest Earned was $5.15 in Q1 2024, with the low at -$3.67 in Q2 2022.
- Historically, Times Interest Earned has averaged -$1.0 across 5 years, with a median of -$1.14 in 2025.
- The largest YoY upside for Times Interest Earned was 2200.52% in 2025 against a maximum downside of 122.07% in 2025.
- Esperion Therapeutics' Times Interest Earned stood at -$2.97 in 2022, then advanced by 5.16% to -$2.81 in 2023, then soared by 93.63% to -$0.18 in 2024, then jumped by 2200.52% to $3.77 in 2025, then sank by 108.83% to -$0.33 in 2026.
- The last three Times Interest Earned figures came in at -$0.33 (Q1 2026), $3.77 (Q4 2025), and -$0.45 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | 3.77 |
| Sep 30, 2025 | -0.45 |
| Jun 30, 2025 | 0.35 |
| Mar 31, 2025 | -1.14 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | -1.06 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 5.15 |
| Dec 31, 2023 | -2.81 |
| Sep 30, 2023 | -1.84 |
| Jun 30, 2023 | -2.55 |
| Mar 31, 2023 | -3.38 |
| Dec 31, 2022 | -2.97 |
| Sep 30, 2022 | -2.94 |
| Jun 30, 2022 | -3.67 |
| Mar 31, 2022 | -3.06 |
| Dec 31, 2021 | -4.14 |
| Sep 30, 2021 | -4.08 |
| Jun 30, 2021 | -2.92 |